Major players in the olanzapine market are Aurobindo Pharma Ltd, Teva Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical.
The global Obesity Management Market size is expected to be valued at US$ 1,362.80 million in 2032, with the market developing at a moderate CAGR of 5.1% from 2022 to 2032. The Obesity Management market, predicted to be worth US$ 828.71 million in 2022, is being driven by the significant rise in obesity and obesity-.
Revenue in Q1 2023 decreased 11% driven by a $1.47 billion decline in revenue from COVID-19 antibodies. Excluding COVID-19 antibodies, revenue in Q1 2023.